Application of the continual reassessment method to dose-finding studies in regional anesthesia: An estimate of the ED95 dose for 0.5% bupivacaine for ultrasound-guided supraclavicular block

Anesthesiology

Volumn 119, Issue 1, 2013, Pages 29-35

  Kant, Abhinav ^a,b   Gupta, Pawan Kumar ^a   Zohar, Sarah ^c   Chevret, Sylvie ^c   Hopkins, Philip M ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; LIDOCAINE;

AGED; ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; DERMATOME; DOSE CALCULATION; DOSE RESPONSE; FEMALE; HUMAN; MALE; NERVE BLOCK; PRIORITY JOURNAL; REGIONAL ANESTHESIA; SHOULDER SURGERY; SUPRACLAVICULAR BLOCK;

AGED; ALGORITHMS; ANESTHESIA, CONDUCTION; ANESTHETICS, LOCAL; BRACHIAL PLEXUS; BUPIVACAINE; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE BLOCK; ORTHOPEDIC PROCEDURES; ULTRASONOGRAPHY, INTERVENTIONAL; UPPER EXTREMITY;

EID: 84883207217     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31829764cf     Document Type: Article

References (24)

1. Beale N, Evans B, Plaat F, Columb MO, Lyons G, Stocks GM: Effect of epidural volume extension on dose requirement of intrathecal hyperbaric bupivacaine at Caesarean section. Br J Anaesth 2005; 95:500-3
2. Camorcia M, Capogna G, Columb MO: Estimation of the minimum motor blocking potency ratio for intrathecal bupivacaine and lidocaine. Int J Obstet Anesth 2008; 17:223-7
3. Pace NL, Stylianou MP: Advances in and limitations of upand-down methodology: A précis of clinical use, study design, and dose estimation in anesthesia research. Anes thesiolog y 2007; 107:144-52
4. Dixon WJ, Mood AM: A method for obtaining and analyzing sensitivity data. J Am Stat Assoc 1948; 43:109-26
5. Klaastad O, Sauter AR, Dodgson MS: Brachial plexus block with or without ultrasound guidance. Curr Opin Anaesthesiol 2009; 22:655-60
6. Satsumae T, Tanaka M, Saito S, Inomata S: Convulsions after ropivacaine 300 mg for brachial plexus block. Br J Anaesth 2008; 101:860-2
7. Müller M, Litz RJ, Hüler M, Albrecht DM: Grand mal convulsion and plasma concentrations after intravascular injection of ropivacaine for axillary brachial plexus blockade. Br J Anaesth 2001; 87:784-7
8. Galvin EM, Niehof S, Medina HJ, Zijlstra FJ, van Bommel J, Klein J, Verbrugge SJ: Thermographic temperature measurement compared with pinprick and cold sensation in predicting the effectiveness of regional blocks. Anesth Analg 2006; 102:598-604
9. Gupta PK, Pace NL, Hopkins PM: Effect of body mass index on the ED50 volume of bupivacaine 0.5% for supraclavicular brachial plexus block. Br J Anaesth 2010; 104:490-5
10. O'Quigley J, Pepe M, Fisher L: Continual reassessment method: A practical design for phase 1 clinical trials in cancer. Biometrics 1990; 46:33-48
11. Resche-Rigon M, Zohar S, Chevret S: Adaptive designs for dose-finding in non-cancer phase II trials: Influence of early unexpected outcomes. Clin Trials 2008; 5:595-606
12. Zohar S, Resche-Rigon M, Chevret S: Using the continual reassessment method to estimate the minimum effective dose in phase II dose-finding studies: A case study. Clin Trials 2011; [Epub ahead of print]. doi: 10.1177/ 1740774511411593
13. Zohar S, Chevret S: The continual reassessment method: Comparison of Bayesian stopping rules for dose-ranging studies. Stat Med 2001; 20:2827-43
14. Garrett-Mayer E: The continual reassessment method for dose-finding studies: A tutorial. Clin Trials 2006; 3:57-71
15. Peereboom DM, Supko JG, Carson KA, Batchelor T, Phuphanich S, Lesser G, Mikkelsen T, Mikkelson T, Fisher J, Desideri S, He X, Grossman SA; New Approaches to Brain Tumor Therapy (NABTT ) Consortium: A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas. J Neurooncol 2010; 100:261-8
16. de Bono JS, Kristeleit R, Tolcher A, Fong P, Pacey S, Karavasilis V, Mita M, Shaw H, Workman P, Kaye S, Rowinsky EK, Aherne W, Atadja P, Scott JW, Patnaik A: Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors. Clin Cancer Res 2008; 14:6663-73
17. Saji S, Toi M, Morita S, Iwata H, Ito Y, Ohno S, Kobayashi T, Hozumi Y, Sakamoto J: Dose-finding phase I and pharmacokinetic study of capecitabine (Xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer. Oncology 2007; 72:330-7
18. T reluyer JM, Zohar S, Rey E, Hubert P, Iserin F, Jugie M, Lenclen R, Chevret S, Pons G: Minimum effective dose of midazolam for sedation of mechanically ventilated neonates. J Clin Pharm Ther 2005; 30:479-85
19. Dougherty TB, Porche VH, Thall PF: Maximum tolerated dose of nalmefene in patients receiving epidural fentanyl and dilute bupivacaine for postoperative analgesia. Anes thesiolog y 2000; 92:1010-6
20. Ishizuka N, Ohashi Y: The continual reassessment method and its applications: A Bayesian methodology for phase I cancer clinical trials. Stat Med 2001; 20:2661-81
21. Kapral S, Krafft P, Eibenberger K, Fitzgerald R, Gosch M, Weinstabl C: Ultrasound-guided supraclavicular approach for regional anesthesia of the brachial plexus. Anesth Analg 1994; 78:507-13
22. Pedro JR, Mathias LA, Gozzani JL, Pedro FS, Rittes JC: Supraclavicular brachial plexus block: A comparative clinical study between bupivacaine and levobupivacaine. Rev Bras Anestesiol 2009; 59:665-73
23. Duggan E, El Beheiry H, Perlas A, Lupu M, Nuica A, Chan VW, Brull R: Minimum effective volume of local anesthetic for ultrasound-guided supraclavicular brachial plexus block. Reg Anesth Pain Med 2009; 34:215-8
24. Perlas A, Lobo G, Lo N, Brull R, Chan VW, Karkhanis R: Ultrasound-guided supraclavicular block: Outcome of 510 consecutive cases. Reg Anesth Pain Med 2009; 34:171-6